Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Y5LR
|
|||
| Former ID |
DIB015878
|
|||
| Drug Name |
AEN-100
|
|||
| Synonyms |
Nobeldin; Nobelzin; Wilzin; NPC-02; Wilson's disease therapeutics, Nobel Pharma; Zinc acetate (Wilson's disease); Zinc acetate (Wilson's disease), Nobel Pharma/Orphan Europe/Teva; Zinc acetate (gastroretentive/ sustained-release/ tablet, amyotrophic lateral sclerosis), Adeona Pharmaceuticals
Click to Show/Hide
|
|||
| Indication | Motor neurone disease [ICD-11: 8B60; ICD-10: G12.2; ICD-9: 335.2] | Phase 4 | [1] | |
| Company |
Adeona Pharmaceuticals Inc; Teva Pharmaceutical Industries Ltd
|
|||
| Structure |
 |
Download2D MOL |
||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00004338) Study of Zinc for Wilson Disease. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.